Waters Corp Hits 52-Week High Following Analyst Upgrade and Strong Q2 Earnings

Key Facts

1Waters Corporation stock reached a new 52-week high of $427.10, marking a 38.19% increase over the past year.

2TD Cowen upgraded the stock to 'Buy' with a $475 price target following strong Q2 earnings results.

3Morgan Stanley noted the company's benefit from China's new clinical laboratory service pricing framework.

Reflecting growing analyst optimism in the laboratory instruments sector, Waters Corporation stock reached a new 52-week high of $427.10. According to reports, this rally followed Q2 2026 earnings results that exceeded market expectations, prompting TD Cowen to upgrade the stock to a 'Buy' rating. Analysts also noted that the company is positioned to benefit significantly from China's new clinical laboratory service pricing framework.

In the broader market context, TD Cowen set a price target of $475 for the stock, underpinned by a 38.19% increase over the past year. Per market data, WAT closed at $418.64 on September 16, 2026. Meanwhile, Morgan Stanley, which highlighted the company's favorable positioning in the Chinese diagnostic market, saw its own shares close at $202.51 on the same date.

Investors should watch for price consolidation at these levels, as WAT reached a daily high of $424.73 as of the close on September 16, 2026. With no major upcoming catalysts in the immediate economic calendar for the healthcare equipment sector, the focus remains on the company's ability to capitalize on regulatory shifts in China to sustain its revenue growth.